JP2023134542A5 - - Google Patents

Download PDF

Info

Publication number
JP2023134542A5
JP2023134542A5 JP2023108111A JP2023108111A JP2023134542A5 JP 2023134542 A5 JP2023134542 A5 JP 2023134542A5 JP 2023108111 A JP2023108111 A JP 2023108111A JP 2023108111 A JP2023108111 A JP 2023108111A JP 2023134542 A5 JP2023134542 A5 JP 2023134542A5
Authority
JP
Japan
Prior art keywords
patient
neoantigens
neoantigen
presentation
peptide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023108111A
Other languages
English (en)
Japanese (ja)
Other versions
JP7651623B2 (ja
JP2023134542A (ja
Filing date
Publication date
Priority claimed from JP2019567557A external-priority patent/JP7795291B2/ja
Application filed filed Critical
Publication of JP2023134542A publication Critical patent/JP2023134542A/ja
Publication of JP2023134542A5 publication Critical patent/JP2023134542A5/ja
Priority to JP2025039865A priority Critical patent/JP2025094018A/ja
Application granted granted Critical
Publication of JP7651623B2 publication Critical patent/JP7651623B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023108111A 2017-06-09 2023-06-30 新生抗原の特定、製造、及び使用 Active JP7651623B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025039865A JP2025094018A (ja) 2017-06-09 2025-03-13 新生抗原の特定、製造、及び使用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762517786P 2017-06-09 2017-06-09
US62/517,786 2017-06-09
JP2019567557A JP7795291B2 (ja) 2017-06-09 2018-06-08 新生抗原の特定、製造、及び使用
PCT/US2018/036571 WO2018227030A1 (en) 2017-06-09 2018-06-08 Neoantigen identification, manufacture, and use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019567557A Division JP7795291B2 (ja) 2017-06-09 2018-06-08 新生抗原の特定、製造、及び使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025039865A Division JP2025094018A (ja) 2017-06-09 2025-03-13 新生抗原の特定、製造、及び使用

Publications (3)

Publication Number Publication Date
JP2023134542A JP2023134542A (ja) 2023-09-27
JP2023134542A5 true JP2023134542A5 (https=) 2024-07-16
JP7651623B2 JP7651623B2 (ja) 2025-03-26

Family

ID=64566322

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019567557A Active JP7795291B2 (ja) 2017-06-09 2018-06-08 新生抗原の特定、製造、及び使用
JP2023108111A Active JP7651623B2 (ja) 2017-06-09 2023-06-30 新生抗原の特定、製造、及び使用
JP2025039865A Pending JP2025094018A (ja) 2017-06-09 2025-03-13 新生抗原の特定、製造、及び使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019567557A Active JP7795291B2 (ja) 2017-06-09 2018-06-08 新生抗原の特定、製造、及び使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025039865A Pending JP2025094018A (ja) 2017-06-09 2025-03-13 新生抗原の特定、製造、及び使用

Country Status (10)

Country Link
US (1) US20200105377A1 (https=)
EP (2) EP3635594B1 (https=)
JP (3) JP7795291B2 (https=)
KR (2) KR20240165471A (https=)
CN (1) CN110720127A (https=)
AU (1) AU2018279627B2 (https=)
CA (1) CA3066635A1 (https=)
IL (1) IL271038A (https=)
SG (1) SG11201911620PA (https=)
WO (1) WO2018227030A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014180490A1 (en) 2013-05-10 2014-11-13 Biontech Ag Predicting immunogenicity of t cell epitopes
WO2016128060A1 (en) 2015-02-12 2016-08-18 Biontech Ag Predicting t cell epitopes useful for vaccination
RU2729116C2 (ru) 2015-12-16 2020-08-04 Гритстоун Онколоджи, Инк. Идентификация, производство и применение неоантигенов
WO2017194170A1 (en) 2016-05-13 2017-11-16 Biontech Rna Pharmaceuticals Gmbh Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
MX2019013259A (es) 2017-05-08 2020-01-13 Gritstone Oncology Inc Vectores de neoantigeno de alfavirus.
WO2018224166A1 (en) 2017-06-09 2018-12-13 Biontech Rna Pharmaceuticals Gmbh Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
KR20260039788A (ko) 2017-10-10 2026-03-20 시애틀 프로젝트 코포레이션 핫스팟을 이용한 신생항원 동정
CA3083097A1 (en) 2017-11-22 2019-05-31 Gritstone Oncology, Inc. Reducing junction epitope presentation for neoantigens
CN112368386A (zh) * 2018-05-23 2021-02-12 磨石肿瘤生物技术公司 共有抗原
US11599774B2 (en) * 2019-03-29 2023-03-07 International Business Machines Corporation Training machine learning model
MX2021014525A (es) 2019-05-30 2022-03-17 Gritstone Bio Inc Adenovirus modificados.
CN114761041A (zh) 2019-07-16 2022-07-15 吉利德科学公司 Hiv疫苗及其制备和使用方法
CN111303268B (zh) * 2020-03-10 2021-08-27 江苏兰恩生物治疗技术研究院有限公司 子宫肌瘤新抗原、其应用和子宫肌瘤疫苗
KR102159921B1 (ko) * 2020-03-24 2020-09-25 주식회사 테라젠바이오 펩타이드 서열 및 hla 대립유전자 서열을 이용하여 신생항원을 예측하는 방법 및 컴퓨터 프로그램
WO2022013154A1 (en) * 2020-07-14 2022-01-20 Myneo Nv Method, system and computer program product for determining presentation likelihoods of neoantigens
KR20230046313A (ko) 2020-08-06 2023-04-05 그릿스톤 바이오, 인코포레이티드 다중에피토프 백신 카세트
CN112210596B (zh) * 2020-09-08 2022-04-26 中生康元生物科技(北京)有限公司 基于基因融合事件的肿瘤新生抗原预测方法及其应用
CN114333998B (zh) * 2020-10-10 2024-10-15 格源致善(上海)生物科技有限公司 一种基于深度学习模型的肿瘤新抗原预测方法及新生抗原预测系统
CN112309502B (zh) * 2020-10-14 2024-09-20 深圳市新合生物医疗科技有限公司 一种计算肿瘤新抗原负荷的方法及系统
EP4213158A1 (en) 2020-11-13 2023-07-19 Ahead Biocomputing, Co. Ltd Information processing device, information processing method, recording medium recording information processing program, and information processing system
EP4277652A1 (en) 2021-01-14 2023-11-22 Gilead Sciences, Inc. Hiv vaccines and methods of using
JP7057003B1 (ja) 2021-02-26 2022-04-19 国立大学法人東京工業大学 予測装置、学習済みモデルの生成装置、予測方法、学習済みモデルの生成方法、予測プログラム、及び学習済みモデルの生成プログラム
JP7057004B1 (ja) 2021-03-05 2022-04-19 国立大学法人東京工業大学 予測装置、学習済みモデルの生成装置、予測方法、学習済みモデルの生成方法、予測プログラム、及び学習済みモデルの生成プログラム
WO2022197630A1 (en) * 2021-03-15 2022-09-22 Amazon Technologies, Inc. Methods for optimizing tumor vaccine antigen coverage for heterogenous malignancies
CA3216276A1 (en) 2021-04-29 2022-11-03 Yardena Samuels T cell receptors directed against ras-derived recurrent neoantigens and methods of identifying same
EP4148146A1 (en) * 2021-09-13 2023-03-15 OncoDNA Method to generate personalized neoantigens of a tumor of a patient
JP2024533501A (ja) * 2021-09-13 2024-09-12 オンコディーエヌエー 患者の腫瘍の個別化された新生抗原を生成する方法
CN117690495A (zh) * 2023-12-15 2024-03-12 南京鼓楼医院 一种肿瘤新抗原预测方法、系统、电子设备及存储介质
CN117711487B (zh) * 2024-02-05 2024-05-17 广州嘉检医学检测有限公司 胚系SNV、InDel变异的鉴定方法、系统以及可读存储介质
CN118262793B (zh) * 2024-03-05 2025-01-03 复旦大学附属肿瘤医院 一种选择多价肿瘤新抗原组合系统和方法
WO2025207836A1 (en) * 2024-03-26 2025-10-02 Wenyi Wang Methods for selecting cancer patients for immunotherapy using subclonal mutation analysis
CN118351934B (zh) * 2024-04-26 2025-01-28 广州润生细胞医药科技有限责任公司 一种基于二代测序数据的肿瘤新抗原识别方法及系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US5019369A (en) 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
ATE157012T1 (de) 1989-11-03 1997-09-15 Univ Vanderbilt Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5204253A (en) 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
EP0646178A1 (en) 1992-06-04 1995-04-05 The Regents Of The University Of California expression cassette with regularoty regions functional in the mammmlian host
US5849589A (en) 1996-03-11 1998-12-15 Duke University Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing
US7283337B2 (en) 2005-03-04 2007-10-16 Headway Technologies, Inc. Abutted exchange bias design for sensor stabilization
CA2879024A1 (en) * 2012-07-12 2014-01-16 Persimmune, Inc. Personalized cancer vaccines and adoptive immune cell therapies
CN118750591A (zh) * 2013-04-07 2024-10-11 博德研究所 用于个性化瘤形成疫苗的组合物和方法

Similar Documents

Publication Publication Date Title
JP2023134542A5 (https=)
JP2025094018A5 (https=)
JP2025065197A5 (https=)
JP2020536553A5 (https=)
JP2025143480A5 (https=)
JP2020532323A5 (https=)
JPWO2019168984A5 (https=)
Smith et al. The sea lamprey germline genome provides insights into programmed genome rearrangement and vertebrate evolution
JP7606528B2 (ja) ペプチド及びhla対立遺伝子配列を用いて新生抗原を予測する方法及びコンピュータプログラム
JP2021503897A5 (https=)
RU2019136762A (ru) Идентификация, производство и применение неоантигенов
Tan et al. The whale shark genome reveals patterns of vertebrate gene family evolution
JPWO2020181240A5 (https=)
US20260057964A1 (en) Method and system of targeting epitopes for neoantigen-based immunotherapy
CN118685530B (zh) 一种非典型新抗原的筛选方法
Codner et al. Constraints on haplotype structure and variable gene frequencies suggest a functional hierarchy within cattle MHC class I
JP2024178175A5 (https=)
Yoshida et al. Genome structure analysis of molluscs revealed whole genome duplication and lineage specific repeat variation
CN114929899A (zh) 一种新抗原的筛选方法、系统及其用途
Gilchrist et al. A pipeline for the systematic identification of non-redundant full-ORF cDNAs for polymorphic and evolutionary divergent genomes: Application to the ascidian Ciona intestinalis
CN111696628A (zh) 新生抗原的鉴定方法
CN115747327A (zh) 涉及移码突变的新抗原预测方法
Soni et al. A whole-genome scan for evidence of positive and balancing selection in aye-ayes (Daubentonia madagascariensis) utilizing a well-fit evolutionary baseline model
JPWO2022207925A5 (https=)
NZ759958B2 (en) Neoantigen identification, manufacture, and use